Published in Electrophoresis on October 17, 2011
Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem (1999) 11.87
Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med (2008) 7.05
Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 5.96
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol (2008) 4.46
In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials (2003) 4.26
Low-molecular-weight heparins. N Engl J Med (1997) 3.19
Production and chemical processing of low molecular weight heparins. Semin Thromb Hemost (1999) 2.07
Polyamine metabolism and cancer. J Cell Mol Med (2003) 1.91
Conformational changes and anticoagulant activity of chondroitin sulfate following its O-sulfonation. Carbohydr Res (1998) 1.79
Heparin and heparan sulfate biosynthesis. IUBMB Life (2002) 1.69
Biosynthesis of chondroitin/dermatan sulfate. IUBMB Life (2002) 1.58
Orthogonal analytical approaches to detect potential contaminants in heparin. Proc Natl Acad Sci U S A (2009) 1.36
Surfen, a small molecule antagonist of heparan sulfate. Proc Natl Acad Sci U S A (2008) 1.26
Analysis of pharmaceutical heparins and potential contaminants using (1)H-NMR and PAGE. J Pharm Sci (2009) 1.16
Degradable gene carriers based on oligomerized polyamines. Eur J Pharm Sci (2006) 1.09
Semi-rigid solution structures of heparin by constrained X-ray scattering modelling: new insight into heparin-protein complexes. J Mol Biol (2009) 1.05
Protamine sulphate, heparin, and blood coagulation. J Clin Invest (1949) 1.04
Chemical Sulfation of Small Molecules - Advances and Challenges. Tetrahedron (2010) 1.03
Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations. Anal Biochem (2009) 1.02
Capillary electrophoresis of complex natural polysaccharides. Electrophoresis (2008) 0.99
Advances in the separation, sensitive detection, and characterization of heparin and heparan sulfate. Anal Bioanal Chem (2008) 0.98
Structural characterization of chondroitin/dermatan sulfate oligosaccharides from bovine aorta by capillary electrophoresis and electrospray ionization quadrupole time-of-flight tandem mass spectrometry. Rapid Commun Mass Spectrom (2002) 0.97
Quality assessment of unfractionated heparin using 1H nuclear magnetic resonance spectroscopy. J Pharm Biomed Anal (2008) 0.95
Hyphenated techniques for the analysis of heparin and heparan sulfate. Anal Bioanal Chem (2010) 0.95
Analysis of heparin sodium by SAX/HPLC for contaminants and impurities. J Pharm Biomed Anal (2008) 0.92
Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate. J Pharm Biomed Anal (2009) 0.89
Analysis of glycosaminoglycan-derived disaccharides in biologic samples by capillary electrophoresis and protocol for sequencing glycosaminoglycans. Biomed Chromatogr (2002) 0.87
Effective reversed-phase ion pair high-performance liquid chromatography method for the separation and characterization of intact low-molecular-weight heparins. Anal Biochem (2009) 0.85
Assessment of oversulfated chondroitin sulfate in low molecular weight and unfractioned heparins diffusion ordered nuclear magnetic resonance spectroscopy method. J Med Chem (2008) 0.85
Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis. J Chromatogr A (2009) 0.85
Analysis and characterization of heparin impurities. Anal Bioanal Chem (2010) 0.84
Capillary electrophoresis fingerprinting, quantification and mass-identification of various 9-aminopyrene-1,4,6-trisulfonate-derivatized oligomers derived from plant polysaccharides. J Chromatogr A (2006) 0.83
Further characterization of the binding of heparin to granulocyte colony-stimulating factor: importance of sulfate groups. Electrophoresis (2008) 0.82
Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approaches. J Pharm Biomed Anal (2010) 0.82
Synthesis of linear polyamines with different amine spacings and their ability to form dsDNA/siRNA complexes suitable for transfection. Macromol Biosci (2010) 0.81
On-line NMR detection of microgram quantities of heparin-derived oligosaccharides and their structure elucidation by microcoil NMR. Anal Bioanal Chem (2007) 0.81
Capillary electrophoretic study of small, highly sulfated, non-sugar molecules interacting with antithrombin. Electrophoresis (2009) 0.80
An assessment of polydispersed species in unfractionated and low molecular weight heparins by diffusion ordered nuclear magnetic resonance spectroscopy method. J Pharm Biomed Anal (2010) 0.79
Determination of dissociation constants between polyelectrolytes and proteins by affinity capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.79
A capillary electrophoretic method for fingerprinting low molecular weight heparins. Anal Biochem (2008) 0.79
Characterization of currently marketed heparin products: key tests for quality assurance. Anal Bioanal Chem (2010) 0.79
Differentiation of the low-molecular-weight heparins. Pharmacotherapy (2001) 0.78
Effects of ionic strength, temperature and conformation on affinity interactions of β₂-glycoprotein I monitored by capillary electrophoresis. Electrophoresis (2011) 0.77
Novel chemo-enzymatic oligomers of cinnamic acids as direct and indirect inhibitors of coagulation proteinases. Bioorg Med Chem (2006) 1.33
A novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids. J Biol Chem (2007) 1.33
Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s). J Med Chem (2006) 1.28
Rapid and efficient microwave-assisted synthesis of highly sulfated organic scaffolds. Tetrahedron Lett (2007) 1.17
Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin. J Biol Chem (2002) 1.14
Interaction of designed sulfated flavanoids with antithrombin: lessons on the design of organic activators. J Med Chem (2002) 1.13
Designing small, nonsugar activators of antithrombin using hydropathic interaction analyses. J Med Chem (2002) 1.10
Characterization of the plasma and blood anticoagulant potential of structurally and mechanistically novel oligomers of 4-hydroxycinnamic acids. Blood Coagul Fibrinolysis (2009) 1.10
Interaction of antithrombin with sulfated, low molecular weight lignins: opportunities for potent, selective modulation of antithrombin function. J Biol Chem (2009) 1.04
Chemical Sulfation of Small Molecules - Advances and Challenges. Tetrahedron (2010) 1.03
First steps in the direction of synthetic, allosteric, direct inhibitors of thrombin and factor Xa. Bioorg Med Chem Lett (2009) 1.00
Rational design of potent, small, synthetic allosteric inhibitors of thrombin. J Med Chem (2011) 0.99
Study of physico-chemical properties of novel highly sulfated, aromatic, mimetics of heparin and heparan sulfate. J Pharm Sci (2010) 0.98
Sulfated, low-molecular-weight lignins are potent inhibitorsof plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies. Thromb Haemost (2009) 0.97
Sulfated pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa. J Med Chem (2013) 0.97
Importance of lysine 125 for heparin binding and activation of antithrombin. Biochemistry (2002) 0.96
On designing non-saccharide, allosteric activators of antithrombin. Eur J Med Chem (2008) 0.96
Synthesis of per-sulfated flavonoids using 2,2,2-trichloro ethyl protecting group and their factor Xa inhibition potential. Bioorg Med Chem (2005) 0.95
Interaction of thrombin with sucrose octasulfate. Biochemistry (2011) 0.95
Understanding Dermatan Sulfate-Heparin Cofactor II Interaction through Virtual Library Screening. ACS Med Chem Lett (2010) 0.93
Exploring new non-sugar sulfated molecules as activators of antithrombin. Bioorg Med Chem Lett (2003) 0.92
Sulfated, low molecular weight lignins inhibit a select group of heparin-binding serine proteases. Biochem Biophys Res Commun (2011) 0.91
1,2-dithiole-3-ones as potent inhibitors of the bacterial 3-ketoacyl acyl carrier protein synthase III (FabH). Antimicrob Agents Chemother (2004) 0.91
Serpin-glycosaminoglycan interactions. Methods Enzymol (2011) 0.91
Identification of the site of binding of sulfated, low molecular weight lignins on thrombin. Biochem Biophys Res Commun (2011) 0.90
Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site. J Med Chem (2013) 0.90
Designing allosteric regulators of thrombin. Exosite 2 features multiple subsites that can be targeted by sulfated small molecules for inducing inhibition. J Med Chem (2013) 0.90
Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa. J Med Chem (2011) 0.90
On the specificity of heparin/heparan sulfate binding to proteins. Anion-binding sites on antithrombin and thrombin are fundamentally different. PLoS One (2012) 0.88
Recent research developments in the direct inhibition of coagulation proteinases--inhibitors of the initiation phase. Cardiovasc Hematol Agents Med Chem (2008) 0.87
Viral inhibition studies on sulfated lignin, a chemically modified biopolymer and a potential mimic of heparan sulfate. Biomacromolecules (2007) 0.87
Designing allosteric regulators of thrombin. Monosulfated benzofuran dimers selectively interact with Arg173 of exosite 2 to induce inhibition. J Med Chem (2012) 0.86
Capillary electrophoresis of highly sulfated flavanoids and flavonoids. Anal Biochem (2005) 0.83
Chemoenzymatically prepared heparan sulfate containing rare 2-O-sulfonated glucuronic acid residues. ACS Chem Biol (2015) 0.83
Synthetic, non-saccharide, glycosaminoglycan mimetics selectively target colon cancer stem cells. ACS Chem Biol (2014) 0.83
Mechanism of poly(acrylic acid) acceleration of antithrombin inhibition of thrombin: implications for the design of novel heparin mimics. J Med Chem (2005) 0.83
The promise of sulfated synthetic small molecules as modulators of glycosaminoglycan function. Future Med Chem (2013) 0.83
Glycosaminoglycan-protein interaction studies using fluorescence spectroscopy. Methods Mol Biol (2015) 0.82
Antithrombin activation by nonsulfated, non-polysaccharide organic polymer. J Med Chem (2005) 0.82
Allosteric inhibition of human factor XIa: discovery of monosulfated benzofurans as a class of promising inhibitors. J Med Chem (2014) 0.81
Targeting the GPIbα binding site of thrombin to simultaneously induce dual anticoagulant and antiplatelet effects. J Med Chem (2014) 0.81
Designing allosteric inhibitors of factor XIa. Lessons from the interactions of sulfated pentagalloylglucopyranosides. J Med Chem (2014) 0.81
Structural characterization of a serendipitously discovered bioactive macromolecule, lignin sulfate. Biomacromolecules (2005) 0.81
Capillary electrophoretic study of small, highly sulfated, non-sugar molecules interacting with antithrombin. Electrophoresis (2009) 0.80
Discovery of novel sulfonated small molecules that inhibit vascular tube formation. Bioorg Med Chem Lett (2012) 0.80
Importance of tryptophan 49 of antithrombin in heparin binding and conformational activation. Biochemistry (2005) 0.80
Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change. Biochemistry (2004) 0.80
Sulfation patterns determine cellular internalization of heparin-like polysaccharides. Mol Pharm (2013) 0.80
Designing "high-affinity, high-specificity" glycosaminoglycan sequences through computerized modeling. Methods Mol Biol (2015) 0.79
A nanosensor for ultrasensitive detection of oversulfated chondroitin sulfate contaminant in heparin. J Am Chem Soc (2014) 0.79
A capillary electrophoretic method for fingerprinting low molecular weight heparins. Anal Biochem (2008) 0.79
On scaffold hopping: challenges in the discovery of sulfated small molecules as mimetics of glycosaminoglycans. Bioorg Med Chem Lett (2012) 0.78
The compensatory G88R change is essential in restoring the normal functions of influenza A/WSN/33 virus matrix protein 1 with a disrupted nuclear localization signal. J Virol (2012) 0.78
Hydropathic interaction analyses of small organic activators binding to antithrombin. Bioorg Med Chem (2004) 0.78
Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders. Med Res Rev (2014) 0.78
Nonsulfated, cinnamic acid-based lignins are potent antagonists of HSV-1 entry into cells. Biomacromolecules (2010) 0.78
Novel low molecular weight lignins as potential anti-emphysema agents: In vitro triple inhibitory activity against elastase, oxidation and inflammation. Pulm Pharmacol Ther (2012) 0.77
Synthesis of biologically relevant biflavanoids--a review. Chem Biodivers (2007) 0.77
Discovery methodology for the development of direct factor VIIa inhibitors. Expert Opin Drug Discov (2014) 0.77
Training the next generation of biomedical investigators in glycosciences. J Clin Invest (2016) 0.76
Electronically Rich N-Substituted Tetrahydroisoquinoline 3-Carboxylic Acid Esters: Concise Synthesis and Conformational Studies. Tetrahedron (2012) 0.76
Synthesis of glycosaminoglycan mimetics through sulfation of polyphenols. Methods Mol Biol (2015) 0.75
Dynamic affinity chromatography in the separation of sulfated lignins binding to thrombin. J Chromatogr B Analyt Technol Biomed Life Sci (2012) 0.75
Potent direct inhibitors of factor Xa based on the tetrahydroisoquinoline scaffold. Eur J Med Chem (2012) 0.75
Preface. Glycosaminoglycans. Methods Mol Biol (2015) 0.75
An update on recent patents on thrombin inhibitors (2010 - 2013). Expert Opin Ther Pat (2013) 0.75
Studying glycosaminoglycan-protein interactions using capillary electrophoresis. Methods Mol Biol (2015) 0.75
Application of molecular connectivity and electro-topological indices in quantitative structure-activity analysis of pyrazole derivatives as inhibitors of factor Xa and thrombin. Chem Biodivers (2008) 0.75